Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-23-019198)

Filing Details

Accession Number:: 0001127602-23-019198
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-22 08:33:09
Reporting Period:: 2023-06-21

Accepted Time:: 2023-06-22 08:33:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591312	I Bassil Dahiyat	C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-21	76,012	$4.25	325,713	No	4	M	Direct
Common Stock	Disposition	2023-06-21	33,497	$26.19	292,216	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-06-21	76,012	$0.00	76,012	$4.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-09-04	2023-09-03	No	4	M	Direct

Footnotes

Underlying option due to expire in September 2023.
Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
Represents first vesting date. Option vested over four years from date of grant.